FIBROMATOSIS

This adverse event was reported 90 times

These drugs are most commonly taken by patients reporting FIBROMATOSIS:

# Drug Count
0 ADALIMUMAB 19
1 ETANERCEPT 10
2 METHOTREXATE 10
3 METHOTREXATE SODIUM 10
4 IBUPFROFEN 8
5 IBUPROFEN 8
6 IBUPROFEN 200 MG 8
7 IBUPROFEN 200MG 8
8 IBUPROFEN CAPSULE 8
9 IBUPROFEN CAPSULES 200 MG 8
See all common drugs associated with FIBROMATOSIS

FIBROMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICLOFENAC SODIUM AND MISOPROSTOL 7 0.0011
1 KETOPROFEN 8 0.0006
2 DACTINOMYCIN 1 0.0005
3 INDOMETHACIN 5 0.0004
4 SELEGILINE 1 0.0003
5 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 2 0.0002
6 PHENYTOIN 4 0.0002
7 TOPOTECAN 1 0.0002
8 SORAFENIB 3 0.0001
9 OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% 1 0.0001
See all drugs enriched for association with FIBROMATOSIS

FIBROMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 1 0.0005
1 Prostaglandin E1 Analog [EPC] 7 0.0004
2 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
3 Interleukin-17A Antagonist [EPC] 7 0.0002
4 Quinolone Antimicrobial [EPC] 1 0.0001
5 Nitrofuran Antibacterial [EPC] 1 0.0001
6 Integrin Receptor Antagonist [EPC] 3 0.0000
7 Anti-IgE [EPC] 3 0.0000
8 Iron Chelator [EPC] 1 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
See all drug classes enriched for association with FIBROMATOSIS